Clinical Trial: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Copeptin After Arginine Infusion for the Differential Diagnosis of the Polyuria-Polydipsia Syndrome ''The CARGO-Study''

Brief Summary: the purpose of the study is to investigate whether arginine infusion is a new tool to differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.

Detailed Summary:
Sponsor: University Hospital, Basel, Switzerland

Current Primary Outcome: Discriminative value of copeptin after arginine infusion in the differential diagnosis of polyuria-polydipsia syndrome. [ Time Frame: up to 120 minutes after the Arginine infusion. ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University Hospital, Basel, Switzerland

Dates:
Date Received: June 12, 2013
Date Started: June 2013
Date Completion: June 2017
Last Updated: March 13, 2017
Last Verified: March 2017